miR-29a-3p targets the PI3K/Akt signaling pathway to suppress inflammation and MMP-9-dependent matrix degradation in spinal tuberculosis Authors: Jiong Wang, Jiaxing Wang, Mengqi Zhu, Yuxin Gao, Linan Wang, Hekun Liu, ZhiYun Shi, Xu Zhang, Ningkui Niu Published: 2026 ABSTRACT AbstractObjectiveSpinal tuberculosis (STB), a prevalent form of extrapulmonary tuberculosis, remains incompletely understood at the mechanistic level. This study investigates the role of miR-29a-3p in modulating STB-associated inflammation and extracellular matrix degradation via targeted regulation of the PI3K/Akt signaling pathway, thereby identifying novel molecular targets for improved diagnosis and therapeutic intervention.MethodsTwenty patients with histopathologically confirmed STB and twenty age- and sex-matched controls with Intervertebral disc degeneration were prospectively enrolled. Genome-wide miRNA profiling was performed on spinal tissue specimens and BCG-infected THP-1–derived macrophages using small RNA sequencing, followed by qRT-PCR validation. Macrophage polarization and mycobacterial infection were modeled by PMA-induced differentiation of THP-1 cells and subsequent challenge with Bacillus Calmette–Guérin (BCG). Functional gain- and loss-of-function assays were conducted via transfection of miR-29a-3p mimics or inhibitors. Cytokine secretion (IL-6, IL-1β, TNF-α) and MMP-9 protein expression were quantified by ELISA, Western blotting, immunofluorescence microscopy, and qRT-PCR. Target prediction and dual-luciferase reporter assays validated direct binding of miR-29a-3p to the 3′-UTR of PI3K. Rescue experiments employed co-treatment with the selective PI3K inhibitor LY294002 to determine pathway-specific dependency.ResultsmiR-29a-3p was significantly downregulated in both STB patient-derived spinal tissue specimens and BCG-infected THP-1–derived macrophages, concomitant with marked upregulation of MMP-9. Overexpression of miR-29a-3p markedly suppressed the secretion of pro-inflammatory cytokines—including IL-6, IL-1β,and TNF-α—as well as MMP-9 protein expression in BCG-infected macrophages; conversely, miR-29a-3p knockdown enhanced the production of these mediators. Mechanistically, miR-29a-3p directly bound to the 3′-UTR of PI3K—thereby inhibiting phosphorylation-dependent activation of the PI3K/Akt signaling axis. Crucially, pharmacological inhibition of PI3K with LY294002 reversed the pro-inflammatory response and matrix degradation effects induced by miR-29a-3p inhibition, confirming the functional dependence of this pathway.ConclusionmiR-29a-3p negatively regulates STB-associated inflammatory responses and MMP-9-mediated matrix degradation by targeting the PI3K/Akt signaling pathway, establishing a novel miR-29a-3p-PI3K/Akt-inflammatory cytokines/MMP-9 regulatory axis. This molecule represents a promising candidate biomarker and therapeutic target for the clinical diagnosis and targeted intervention of STB.Graphical abstractSupplementary InformationThe online version contains supplementary material available at 10.1186/s13018-026-07030-9.Keywords: miR-29a-3p, Spinal tuberculosis, PI3K/Akt signaling pathway, Matrix degradation Introduction Tuberculosis is one of the common infectious diseases in developing countries, among which spinal tuberculosis (STB) is the most common extrapulmonary tuberculosis [1]. STB has insidious onset, unclear pathogenesis, atypical clinical symptoms and limited specificity of existing laboratory tests [1, 2]. Therefore, exploring new diagnostic and therapeutic targets and further studying the pathogenic and progression mechanisms of STB are of great significance for improving the clinical diagnosis and treatment level. The core pathological feature of STB is the inflammatory response, which is regulated by the complex relationship among immune cells, cytokines and regulatory molecules [3]. Macrophages, as the main immune cells after Mycobacterium tuberculosis (MTB) infection in the host, play a key role in the inflammatory response [4]. Relevant studies have confirmed that the phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) signaling pathway is a key pathway for regulating macrophage function and tuberculosis inflammation [5]. This pathway can regulate the recruitment and activation of innate immune cells and affect the secretion of inflammatory factors [6]. MTB virulence factors can promote the release of pro-inflammatory factors such as tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) by activating the PI3K/Akt pathway, thereby helping the bacteria escape host immune surveillance [7]. The role of the PI3K/Akt pathway in tuberculosis suggests that targeting this pathway may become an important direction for the treatment of STB [8]. Non-coding RNAs (ncRNAs), including microRNAs (miRNAs), small interfering RNAs (siRNAs) and long non-coding RNAs (lncRNAs), have emerged as critical regulators of musculoskeletal homeostasis and the pathogenesis of both degenerative and infectious musculoskeletal disorders [9–11]. miRNAs play significant roles in various pathophysiological processes such as infectious diseases and inflammatory responses [12–14]. miRNAs exert their functions by binding to the 3′ untranslated region of mRNAs, thereby inhibiting their translation or promoting transcript degradation [15, 16]. After the host is infected with MTB, the abnormal expression of miRNAs can affect the host’s immune response, such as the differentiation of immune cells and the secretion of inflammatory factors [17]. miR-146a-5p negatively regulates the progression of STB by targeting and inhibiting the TGF-β1/SMADs signaling pathway [18]. Previous studies have shown that miR-29a-3p is differentially expressed in the peripheral blood of patients with active pulmonary tuberculosis, and it has high sensitivity and specificity in distinguishing active pulmonary tuberculosis, latent tuberculosis, and healthy individuals, indicating its potential as a diagnostic biomarker [19]. In diseases such as glioma and nasopharyngeal carcinoma, miR-29a-3p has been confirmed to target and regulate the PI3K/Akt pathway by directly acting on the PI3K gene and inhibiting Akt phosphorylation, thereby influencing cell proliferation and apoptosis [20, 21]. However, the role and mechanism of miR-29a-3p in regulating the PI3K/Akt pathway in the inflammatory response of STB remain unclear. Therefore, this study aims to clarify the expression pattern of miR-29a-3p in STB tissues, explore its regulatory effect on the PI3K/Akt pathway, and reveal its function in the inflammatory response of STB. Methods Study object A total of 40 adult patients scheduled for elective spinal surgery were enrolled from January 2024 to June 2025: 20 with histopathologically confirmed STB formed the experimental group; 20 age- and sex-matched patients with MRI-confirmed Intervertebral disc degeneration (IDD) served as controls. The study was approved by the Institutional Review Board of Ningxia Medical University (No. KYLL-2022-0133), and written informed consent was obtained from all participants. Exclusion criteria included active extraspinal infection, autoimmune disease, malignancy, immunosuppressive therapy within 30 days, major organ dysfunction, pregnancy, psychiatric illness, recent spinal trauma or surgery, and incomplete documentation. All intervertebral disc tissue specimens obtained from surgery were immediately divided into two parts after removal: one portion was snap-frozen for molecular biology analysis, and the other was fixed in 4% paraformaldehyde for immunohistochemistry. Genome-wide miRNA profiling and bioinformatics analysis Total RNA was extracted from intervertebral disc tissues of patients with STB (n = 3) and IDD (n = 3) controls using TRIzol® reagent, followed by quality assessment with the NanoDrop 2000 spectrophotometer and the Agilent 2100 Bioanalyzer system (RNA Integrity Number, RIN ≥ 7.0). One microgram of high-quality total RNA per sample was used to construct small RNA libraries according to the Illumina TruSeq Small RNA Library Prep Kit protocol; libraries were then sequenced on the Illumina NovaSeq 6000 platform using single-end 50 bp (SE50) reads. Raw sequencing data were subjected to rigorous quality control, including removal of adapter sequences, trimming of low-quality reads (Phred score < 20), and exclusion of reads shorter than 18 nt or longer than 30 nt. Clean reads were aligned to the human reference genome (GRCh38/hg38) using miRDeep2, and miRNAs were annotated and quantified based on miRBase v22.1. Differential expression analysis was performed using DESeq2 with significance thresholds set at |log₂(fold change)|> 1 and an adjusted P-value (Benjamini–Hochberg correction) < 0.05. Gene Ontology (GO) functional enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses of the candidate target genes were performed using the clusterProfiler R package. THP-1 cell culture and differentiation induction Human monocytic leukemia–derived THP-1 cells were cultured in RPMI-1640 medium supplemented with 10% heat-inactivated FBS, 2 mM L-glutamine, 1 mM sodium pyruvate, and 10 mM HEPES, under 5% CO₂ at 37 °C. Cells were passaged every 2–3 days at 70–80% confluence and used between passages 5–15. For differentiation, logarithmic-phase cells (2 × 105/well) were treated with 100 nM PMA for 6 h, followed by 48 h resting; adherence and morphological changes confirmed macrophage differentiation. For infection modeling, differentiated macrophages were infected with BCG at MOI 15:1 for 24 h. After 48 h of incubation, the experimental group model of downregulated-infected macrophages was successfully established. Transfection and infection miR-29a-3p mimics, inhibitors, and their respective negative controls (NC) were chemically synthesized and purified by GenePharma Co., Ltd. (Shanghai, China). Transfection was performed using Lipofectamine™ RNAiMAX Transfection Reagent following the manufacturer’s protocol with minor optimizations for THP-1–derived macrophages. Briefly, 5 μL of 20 μM miRNA mimic or inhibitor, 10 μL of RNAiMAX reagent, and 200 μL of serum-free Opti-MEM® I Reduced Serum Medium were combined in a sterile RNase-free tube, gently vortexed, and incubated at room temperature for 20 min to allow formation of stable nucleic acid–lipid complexes. In 6-well plates, miR-29a-3p mimic/inhibitor was transfected at a final concentration of 50 nM.The transfection mixture was then added dropwise to each well of a 6-well plate containing differentiated macrophages (at ~ 70% confluence), followed by gentle rocking to ensure uniform distribution. Cells were incubated under standard culture conditions (37 °C, 5% CO2) for 6 h, after which the medium was replaced with complete RPMI-1640 medium supplemented with 10% FBS. Transfection efficiency was routinely assessed 24 h post-transfection by quantitative real-time PCR (qRT-PCR) measuring mature miR-29a-3p levels.BCG was inoculated into six-well tissue culture plates at a MOI of 15:1 to establish an in vitro macrophage infection model mimicking MTB pathogenesis. Western blotting (WB) Total protein was extracted using a total protein extraction kit and quantified with a BCA protein quantification kit(Keygen Biotech, China). For electrophoresis, 30 μg of total protein per lane was loaded onto 10–12% SDS-PAGE gels and separated under 120 V. Proteins were then electrophoretically transferred onto pre-activated PVDF membranes using a wet transfer system (250 mA, 90 min, 4 °C). Membranes were blocked with 5% non-fat dry milk in TBST for 2 h at room temperature, followed by overnight incubation at 4 °C with primary antibodies: PI3K, AKT and β-actin (Affinity, China,1:1000), p-PI3K and p-Akt (CST, USA,1:1000). After three 10-min washes with TBST, membranes were incubated with HRP-conjugated goat anti-rabbit IgG secondary antibody (Affinity, China,1:10,000) for 2 h at room temperature. Following another three 10-min TBST washes, immunoreactive bands were visualized using enhanced chemiluminescence (ECL) reagent (Servicebio, China) and captured using an Imaging System. Band intensities were quantified using Image J software. Immunohistochemistry (IHC) The lumbar tissue specimens of STB and IDD patients obtained through surgery were fixed with 4% paraformaldehyde and routinely embedded in paraffin, including dehydration, paraffin infiltration, embedding and sectioning. Antigen retrieval was performed by high-temperature treatment. The sections were incubated with 3% hydrogen peroxide at room temperature and then blocked with 5% bovine serum at room temperature. The blocking solution was discarded, and the sections were incubated with MMP-9 primary antibody (Affinity, 1:200) at 4 °C overnight, followed by incubation with biotin-conjugated secondary antibody. The immunoreactivity was visualized with DAB chromogen, and the sections were counterstained with hematoxylin. After dehydration and transparency treatment, the slides were mounted and examined under an optical microscope. Quantitative real-time polymerase chain reaction (qRT-PCR) Total RNA was extracted from cultured cells or tissue samples using an RNA extraction kit (Servicebio, China). First-strand cDNA synthesis and subsequent qRT-PCR amplification were carried out using the Hairpin-it miRNAs qRT-PCR Quantitative Kit (Servicebio, China), strictly according to the manufacturer’s instructions. Reverse transcription was performed at 42 °C for 15 min, followed by inactivation at 37 °C for 5 s; cDNA products were immediately stored at 4 °C. qRT-PCR reactions were run on a real-time PCR detection system under standardized cycling conditions. U6 snRNA and GAPDH mRNA were used as endogenous controls, and relative expression levels were determined using the 2⁻ΔΔCt method (Table 1). Table 1Sequences of primers used for reverse transcription-quantitative PCRGenePrimer sequence (5′ → 3′),S(sense primer),A(antisense primer)miR-29a-3pmiR-29a-3p-RT:CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGTAACCGATmiR-29a-3p-S: ACACTCCAGCTGGGTAGCACCATCTGAATU6U6-S: CTCGCTTCGGCAGCACAU6-A: AACGCTTCACGAATTTGCGTGAPDHH-GAPDH-S: GGAAGCTTGTCATCAATGGAAATCH-GAPDH-A: TGATGACCCTTTTGGCTCCCIL-6H-IL-6-S: TTCGGTCCAGTTGCCTTCTCH-IL-6-A: AGTGCCTCTTTGCTGCTTTCAIL—1βH-IL-1β- S: CCACAGACCTTCCAGGAGAATGH-IL-1β-A:GTGCAGTTCAGTGATCGTACAGGTNF-αH-TNF -α- S: CTCTTCTGCCTGCTGCACTTTGH-TNF -α-A:ATGGGCTACAGGCTTGTCACTC Sequences of primers used for reverse transcription-quantitative PCR miR-29a-3p-RT:CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGTAACCGAT miR-29a-3p-S: ACACTCCAGCTGGGTAGCACCATCTGAAT U6-S: CTCGCTTCGGCAGCACA U6-A: AACGCTTCACGAATTTGCGT H-GAPDH-S: GGAAGCTTGTCATCAATGGAAATC H-GAPDH-A: TGATGACCCTTTTGGCTCCC H-IL-6-S: TTCGGTCCAGTTGCCTTCTC H-IL-6-A: AGTGCCTCTTTGCTGCTTTCA H-IL-1β- S: CCACAGACCTTCCAGGAGAATG H-IL-1β-A:GTGCAGTTCAGTGATCGTACAGG H-TNF -α- S: CTCTTCTGCCTGCTGCACTTTG H-TNF -α-A:ATGGGCTACAGGCTTGTCACTC Immunofluorescence (IF) THP-1-derived macrophages were seeded onto sterile glass cover slips placed in 6-well tissue culture plates. Upon full adherence, cells were gently washed three times with ice-cold phosphate-buffered saline (PBS). Fixation was performed with 4% paraformaldehyde in PBS for 15 min at room temperature, followed by permeabilization with 0.1% Triton X-100 and blocking with 5% bovine serum albumin (BSA) in PBS for 1 h at room temperature. Primary antibodies were applied overnight at 4 °C; after washing, fluorophore-conjugated secondary antibodies were incubated for 1 h at room temperature in the dark. Nuclei were counterstained with DAPI for 5 min. Cover slips were mounted onto glass slides using an anti-fade mounting medium and visualized under a Leica DMi8 fluorescence microscope. Enzyme-linked immunosorbent assay (ELISA) IL-6, IL-1β, and TNF-α concentrations in cell culture supernatants were quantified using commercially available ELISA kits (Servicebio, China), according to the manufacturer’s instructions. Standard curves were generated from serially diluted recombinant cytokine standards included in each kit, and sample concentrations were interpolated accordingly. All assays were performed in technical triplicate, and biological experiments were independently repeated three times. Dual-luciferase reporter assay Putative binding sites of miR-29a-3p within the 3′UTR of PI3K were predicted using TargetScan. Wild-type (WT) and site-directed mutant (MUT) fragments of the PI3K 3′UTR containing the predicted miR-29a-3p seed-matching sequence were cloned downstream of the firefly luciferase gene in the pmirGLO dual-luciferase reporter vector(Gene Create, China). THP-1 cells were co-transfected with each reporter construct and either miR-29a-3p mimics, miR-29a-3p inhibitors,NC mimics, or NC inhibitors using Lipofectamine 3000. At 48 h post-transfection, luciferase activity was measured using the Dual-Luciferase Reporter Assay System. Statistical analysis Statistical analyses were performed using SPSS 26.0 and GraphPad Prism 10.1.0. Data are expressed as mean ± standard deviation (SD). Normality was assessed using the Shapiro–Wilk test, and homogeneity of variance was evaluated by Levene’s test. For parametric data, comparisons between two groups were conducted using two-tailed unpaired Student’s t-tests; for multiple-group comparisons, one-way analysis of variance (ANOVA) followed by Dunnett’s post hoc test (vs. control group) was applied. Non-parametric alternatives—including the Mann–Whitney U test for two-group comparisons and the Kruskal–Wallis H test with Dunn’s post hoc correction for multiple-group comparisons—were used when assumptions of normality or equal variance were violated. Statistical significance was defined as P < 0.05. Results miR-29a-3p is downregulated in STB and its predicted targets are functionally enriched miRNA sequencing was performed on STB and IDD tissues to screen for differentially expressed miRNAs. The results showed that miR-29a-3p was significantly downregulated in STB (Fig. 1A,B). To explore the potential biological functions of miR-29a-3p, bioinformatics enrichment analysis of its target genes was performed using the TargetScan database. GO functional enrichment analysis indicated that the target genes of miR-29a-3p were mainly enriched in ECM-related biological processes and cell adhesion regulation (Fig. 1C). KEGG pathway enrichment analysis revealed that its target genes were significantly enriched in the PI3K/Akt signaling pathway, with the highest enrichment degree in this pathway. In summary, the target genes of miR-29a-3p are involved in the regulation of molecular functions related to extracellular matrix structure and are significantly enriched in key pathways such as PI3K/Akt that mediate inflammatory responses and matrix metabolism. This suggests that miR-29a-3p may participate in the pathological process of STB inflammation and matrix degradation by regulating the above biological functions and signaling pathways mediated by its target genes. miR-29a-3p is downregulated in STB tissues and targets the PI3K/Akt signaling pathway downstream. A Cluster heatmap of miRNAs expression in STB and IDD tissues; B Volcano plot of differentially expressed miRNAs in STB and IDD tissues; C GO functional enrichment analysis of miR-29a-3p target genes; D KEGG enrichment analysis of miR-29a-3p target genes Validation of the expression of miR-29a-3p in STB To verify the sequencing results, qRT-PCR was used to detect the expression of miR-29a-3p in 20 cases of STB and IDD tissues respectively. The expression of miR-29a-3p was significantly decreased in STB tissues (Fig. 2A), which was consistent with the sequencing results; the expression of miR-29a-3p was also significantly decreased in BCG-infected cells (Fig. 2B). Western Blotting (Fig. 2C), IF (Fig. 2C,E) showed that the expression of MMP-9 was upregulated in the BCG infection group, and IHC showed that the expression of Matrix Metalloproteinase-9 (MMP-9) was significantly increased in STB tissues (Fig. 2D). This suggests that the abnormal expression of miR-29a-3p and MMP-9 are closely related to the pathological process of STB, and they may be involved in its occurrence and development in a synergistic manner. Low expression of miR-29a-3p and high expression of MMP-9 in STB tissues and BCG-infected THP-1 macrophage models. A, B miR-29a-3p was found to be downregulated in both STB tissues and BCG-infected THP-1 macrophage models as detected by qRT-PCR; C–E WB, IHC, and IF analyses, together with corresponding quantitative assessments, revealed elevated MMP-9 expression in both STB-infected clinical tissue samples and cellular models. **P < 0.01, ***P < 0.001; error bars represent mean ± standard deviation (SD) Screening results of the optimal conditions for BCG infection in macrophages To determine the optimal conditions for BCG infection of macrophages to establish a stable in vitro infection model, we measured the secretion levels of IL-6, IL-1β, and TNF-α in macrophage culture supernatants using ELISA under different multiplicity of infection (MOI: 0, 5, 10, 15, 20) and various infection durations (0, 6, 12, 24, 36 h).The optimal conditions for BCG infection were screened based on these results. The results showed that the secretion levels of pro-inflammatory factors increased first and then remained stable with the increase of MOI and the extension of incubation time. When MOI was 15 and the incubation time was 24 h, the secretion levels of IL-6, IL-1β, and TNF-α all reached the peak and the detection results were stable. Under these conditions, a highly active BCG-infected macrophage model could be successfully constructed, laying a foundation for subsequent experiments (Fig. 3A–E). ELISA screening for the optimal conditions of BCG infection in THP-1-derived macrophages. A–C When the incubation time was fixed at 24 h, the secretion levels of pro-inflammatory factors in macrophages gradually increased with different BCG infection multiplicities, reaching a relatively high level at MOI = 15; D–F When the BCG infection multiplicity was fixed at 15, the secretion levels of pro-inflammatory factors in macrophages showed a trend of first increasing and then stabilizing at different incubation times, reaching the secretion peak at 24 h of incubation. **P < 0.01, ***P < 0.001; error bars represent mean ± SD Regulatory effects of miR-29a-3p on inflammatory factors and MMP-9 in macrophages To clarify the regulatory effect of miR-29a-3p on the inflammatory response of STB, miR-29a-3p mimic, inhibitor and their corresponding negative controls were transfected into BCG-infected macrophages, and the expression of inflammatory factors and MMP-9 was detected. Immunofluorescence showed that miR-29a-3p mimic could significantly reduce the fluorescence intensity of IL-1β, IL-6 and TNF-α, while inhibitor could significantly enhance it (Fig. 4A–C). The levels of TNF-α, IL-6, and IL-1β mRNA in cells detected by qRT-PCR were consistent with these results (Fig. 4E–G). Western Blotting indicated that mimic could down-regulate the expression of MMP-9, while inhibitor could up-regulate it (Fig. 4D). The above results confirmed that miR-29a-3p could negatively regulate the secretion of inflammatory factors and the expression of MMP-9 in BCG-infected macrophages. Regulation of miR-29a-3p on the expression of inflammatory factors and MMP-9 in BCG-infected macrophages. A–C The protein expression levels of IL-1β, IL-6 and TNF-α in the cells of each experimental group were detected by IF and quantitative analysis was conducted based on the relative fluorescence intensity; D The protein expression levels of MMP-9 in cells from each experimental group were assessed by WB, with quantification performed by normalizing the MMP-9 band intensity to that of β-actin; E–G The expression of IL-1β, IL-6, and TNF-α mRNA in cells of each group was detected by qRT-PCR. **P < 0.01, ***P < 0.001; error bars represent mean ± SD Verification of the regulatory role and mechanism of miR-29a-3p on the PI3K/Akt pathway To investigate the potential molecular mechanisms by which miR-29a-3p regulates macrophage resistance to BCG infection, we first performed KEGG pathway enrichment analysis on differentially expressed genes obtained in previous studies. The results showed significant enrichment of the PI3K/Akt signaling pathway, suggesting that this pathway may be a key downstream target for miR-29a-3p function. Therefore, we further validated the regulatory role and underlying mechanism of miR-29a-3p on the PI3K/Akt pathway.Western Blot results showed that BCG infection could significantly up-regulate the expression of p-PI3K and p-Akt, with no significant change in the levels of total PI3K and total Akt proteins, suggesting that BCG could activate the phosphorylation of the PI3K/Akt pathway (Fig. 5A).To verify whether miR-29a-3p directly targets the 3′UTR of the PI3K gene, we performed a dual luciferase reporter assay. This assay measured the ratio of firefly luciferase activity to renilla luciferase activity by co-transfecting reporter vectors containing the PI3K 3′UTR with miR-29a-3p mimics or inhibitors. Overexpression of miR-29a-3p could inhibit the BCG-induced up-regulation of p-PI3K and p-Akt, while inhibition of miR-29a-3p had the opposite effect (Fig. 5B). Dual-luciferase assay confirmed that miR-29a-3p could directly target PI3K, thereby negatively regulating the phosphorylation and activation of the PI3K/Akt pathway (Fig. 5C). miR-29a-3p negatively regulates the PI3K/Akt signaling pathway in BCG-infected macrophages by directly targeting and binding to PI3K. A Western Blotting was used to detect the expression of proteins related to the PI3K/Akt pathway in BCG-infected and uninfected groups; B Western Blotting was used to detect the expression of proteins related to the PI3K/Akt pathway in each group after miR-29a-3p transfection; C Dual-luciferase reporter gene assay was used to verify the targeted binding relationship between miR-29a-3p and PI3K. *P < 0.05, **P < 0.01, ***P < 0.001; error bars represent mean ± SD miR-29a-3p regulates STB inflammation and matrix degradation via the PI3K/Akt pathway To clarify whether miR-29a-3p regulates the inflammatory response of STB through the PI3K/Akt pathway, BCG-infected macrophages were treated with the PI3K/Akt pathway-specific inhibitor LY294002 in combination with miR-29a-3p inhibitor. Western Blotting results showed that compared with the miR-29a-3p inhibitor alone treatment group, the expression of MMP-9 protein was significantly downregulated in the miR-29a-3p inhibitor + LY294002 combined treatment group (Fig. 6A). ELISA detection indicated that LY294002 could significantly reverse the upregulation of IL-6, IL-1β, and TNF-α by miR-29a-3p inhibitor, and the secretion levels of the three pro-inflammatory factors in the combined treatment group were significantly lower than those in the miR-29a-3p inhibitor alone group (Fig. 6B). The qRT-PCR results were consistent with those of ELISA (Fig. 6C). The above results suggest that the regulatory effect of miR-29a-3p on STB inflammation and matrix degradation depends on the mediation of the PI3K/Akt pathway. Reversal effects of PI3K/Akt pathway inhibitors on the upregulation of MMP-9 and inflammatory factors mediated by miR-29a-3p inhibitors. A Western Blotting was used to detect the expression of MMP-9 protein in each group of cells,the left panel shows representative gel images, the right bar graph displays the relative expression levels of MMP-9 bands, normalized to β-actin gray values; B, C ELISA and qRT-PCR were used to detect the secretion levels of IL-6, IL-1β, and TNF-α in the supernatants of each group of cells. *P < 0.05, **P < 0.01, ns indicates no statistical difference; error bars represent mean ± SD Discussion STB, the most common type of extrapulmonary tuberculosis, is characterized by vertebral bone destruction and intervertebral space narrowing, leading to spinal instability and neurological dysfunction, which seriously affects the quality of life of patients [22, 23]. However, the pathogenesis of STB has not been fully elucidated, especially in terms of the lack of systematic research on the regulation of the inflammatory microenvironment and the mechanism of matrix degradation [24]. In this study, through the analysis of clinical samples combined with in vitro cell models, we first revealed the negative regulatory role of the miR-29a-3p/PI3K/Akt signaling axis in the inflammatory response and matrix degradation of STB, providing a new perspective for understanding the molecular pathological mechanism of STB. NcRNA regulatory networks exert multilevel, multitargeted regulatory effects on disease pathogenesis and progression. In the context of bone metabolism disorders, miR-217 modulates the OPG/RANKL/RANK signaling pathway, miR-106a-5p directly targets the PTEN gene, and circular RNAs regulate key bone homeostasis molecules, all of which are critically involved in osteoporosis pathogenesis and represent promising therapeutic targets [25–27]. Beyond bone metabolism, ncRNAs also play pivotal roles in cell apoptosis regulation: lncRNA CRNDE promotes fracture healing by modulating osteoblast viability and apoptosis, while miR-204-5p exerts a protective effect in intervertebral disc degeneration by targeting the SSRP1/NF-κB pathway to inhibit nucleus pulposus cell apoptosis [28, 29]. Importantly, extending beyond musculoskeletal degenerative diseases, miRNAs as key post-transcriptional regulators exert dual effects on the immune response to MTB infection [30]. Previous studies have shown that members of the miR-29 family are differentially expressed in the peripheral blood of patients with active pulmonary tuberculosis and have the potential to serve as diagnostic biomarkers [19, 31]. This study found that miR-29a-3p was significantly downregulated in the lesion tissues of STB patients and in BCG-infected macrophages, and was negatively correlated with the expression of MMP-9, suggesting that the low expression of miR-29a-3p may be a common molecular response induced by MTB infection. Bioinformatics analysis revealed that the target genes of miR-29a-3p were significantly enriched in extracellular matrix regulation and the PI3K/Akt signaling pathway, which is highly consistent with the pathological changes of STB characterized by matrix degradation [32]. Macrophages, as the main target cells of MTB infection, directly determine the direction of the host immune response [33]. In this study, a BCG infection model was established using THP-1-derived macrophages, and it was confirmed that MOI = 15 and incubation for 24 h were the optimal infection conditions. This model can stably simulate the inflammatory microenvironment induced by MTB. Functional experiments showed that overexpression of miR-29a-3p could significantly inhibit the secretion of pro-inflammatory factors such as IL-6, IL-1β, and TNF-α and the expression of MMP-9 protein in BCG-infected macrophages, while knockdown of miR-29a-3p had the opposite effect. This result is consistent with the negative regulatory role of the miR-29 family in chronic inflammatory bone diseases such as rheumatoid arthritis, suggesting that miR-29a-3p may maintain tissue homeostasis by inhibiting excessive inflammatory responses and matrix degradation [34]. The PI3K/Akt signaling pathway is a key hub for regulating macrophage function and tuberculosis inflammatory responses [35, 36]. downregulated (MTB) virulence factors can activate the Toll-like receptor 4 (TLR4) to initiate the PI3K/Akt pathway, thereby regulating the secretion of inflammatory factors and influencing bacterial survival [37]. This study confirmed that BCG infection can activate the phosphorylation of the PI3K/Akt pathway in macrophages, and overexpression of miR-29a-3p can significantly inhibit the expression of p-PI3K and p-Akt, suggesting that the regulation of this pathway by MTB mainly occurs at the phosphorylation level. The dual-luciferase reporter gene assay confirmed that miR-29a-3p can directly target the 3′UTR region of PI3K. This targeting relationship has been reported in diseases such as glioma and nasopharyngeal carcinoma, and this study extends it to the field of tuberculosis infection, furthering the understanding of the miRNA regulatory network in MTB infection [20, 21]. MMP-9 plays a key role in the formation of tuberculous granulomas and tissue remodeling [38, 39]. Studies have shown that MMP-9 is involved in the recruitment of macrophages and the organization of granuloma structure, and its activity is closely related to the fibrosis and bone destruction of tuberculosis lesions [40, 41]. This study found that miR-29a-3p can negatively regulate the expression of MMP-9, and the PI3K/Akt pathway inhibitor LY294002 can reverse the upregulation of MMP-9 and the increase in inflammatory factor secretion induced by miR-29a-3p inhibitor, confirming that miR-29a-3p regulates STB inflammation and matrix degradation through the PI3K/Akt pathway. The proposal of the miR-29a-3p-PI3K/Akt-inflammatory factor/MMP-9 regulatory axis provides a new theoretical framework for the study of STB pathological mechanisms. Several limitations of this study should be acknowledged. First, the identified regulatory axis was only verified in an in vitro model, lacking in vivo validation in animal models; additionally, the synergistic regulatory effects of miR-29a-3p with other ncRNAs (such as lncRNAs) remain unexplored [42]. Second, the absence of sex-specific effect analysis constitutes another important limitation, given the well-documented immunomodulatory roles of sex hormones [43]. Finally, as recent studies have demonstrated significant strain-specific differences in macrophage immune responses and cell death modes induced by pathogenic MTB H37Rv versus BCG, future experiments involving H37Rv infection should be conducted under Biosafety Level 3 conditions to further validate the universality of this regulatory mechanism [44]. Future research directions include establishing an STB animal model for in vivo verification, dissecting the complexity of the miR-29a-3p regulatory network, and evaluating sex-related effects in an independent STB cohort with sufficient sample size and balanced sex distribution. In conclusion, this study elucidated the molecular mechanism by which miR-29a-3p negatively regulates the inflammatory response of STB and MMP-9-mediated matrix degradation through targeting the PI3K/Akt pathway, expanding the understanding of the pathological mechanism of STB. With the development of RNA interference technology and nanodelivery systems, intervention strategies targeting this regulatory axis are expected to provide new solutions for the precise diagnosis and treatment of STB. Conclusion This study thoroughly expounded the expression characteristics of miR-29a-3p in STB and the molecular mechanism of regulating the PI3K/Akt signaling pathway. The results indicated that this miRNA was significantly down-regulated in STB tissues and BCG-infected macrophages, while MMP-9 was highly expressed. Functional experiments confirmed that overexpression of miR-29a-3p could inhibit the secretion of pro-inflammatory factors and the expression of MMP-9, while knockdown would aggravate the inflammatory response and matrix degradation; it achieved this by targeting the PI3K inhibition pathway and its regulatory effect on STB was dependent on the PI3K/Akt signaling axis. In conclusion, this study has revealed the molecular mechanism by which miR-29a-3p negatively regulates the inflammatory response and matrix degradation of STB through targeting the PI3K/Akt pathway, providing a new potential target for the diagnosis and treatment of STB. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1. Acknowledgements Not applicable. Author contributions WJ and WJX was involved in the conception of the study and writing the manuscript. NNK and ZX provided funds and revised article. ZMQ,GYX and WLN provided technical guidance and revised figures. LHK and SZY collected clinical data. All authors read and approved the final manuscript. Funding This project is financially supported by the National Natural Science Foundation of China (No. 82260436). Autonomous region key research and development plan project (No. 2026BEG02018). Ningxia Natural Science Foundation (No. 2025AAC030752). Data availability Our study only collected the clinical data of patients and did not interfere with the treatment plan of patients. The datasets related to this study are not publicly available due to privacy or ethical restrictions but are available from the corresponding author on reasonable request. Declarations Ethics approval and consent to participate This study was conducted in accordance with the principles of Helsinki Declaration. The study approval was obtained from the Ethics Committee of General Hospital of Ningxia Medical University (KYLL-2022-0133). Consent for publication Not applicable. Competing interests The authors declare that they have no competing interests. Footnotes Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Jiong Wang and Jiaxing Wang have contributed equally to this work. Contributor Information Xu Zhang, Email: xuzhang1012@163.com. Ningkui Niu, Email: niuningkui6743242@163.com. References Associated Data Supplementary Materials Supplementary Material 1. Data Availability Statement Our study only collected the clinical data of patients and did not interfere with the treatment plan of patients. The datasets related to this study are not publicly available due to privacy or ethical restrictions but are available from the corresponding author on reasonable request.